These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11812516)
1. Angiotensin II-induced drinking and pressor responses to central or systemic irbesartan and losartan. Grippo AJ; Kirby RF; Beltz TG; Johnson AK Pharmacol Biochem Behav; 2002; 71(1-2):139-46. PubMed ID: 11812516 [TBL] [Abstract][Full Text] [Related]
2. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Polidori C; Ciccocioppo R; Nisato D; Cazaubon C; Massi M Eur J Pharmacol; 1998 Jul; 352(1):15-21. PubMed ID: 9718262 [TBL] [Abstract][Full Text] [Related]
4. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats. Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634 [TBL] [Abstract][Full Text] [Related]
5. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Hogarty DC; Speakman EA; Puig V; Phillips MI Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162 [TBL] [Abstract][Full Text] [Related]
6. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats. Morita O; Kushida H; Kunihara M J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332 [TBL] [Abstract][Full Text] [Related]
7. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier. Bui JD; Kimura B; Phillips MI Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042 [TBL] [Abstract][Full Text] [Related]
8. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats. Toney GM; Porter JP Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041 [TBL] [Abstract][Full Text] [Related]
9. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat. Kirby RF; Thunhorst RL; Johnson AK Brain Res; 1992 Apr; 576(2):348-50. PubMed ID: 1515929 [TBL] [Abstract][Full Text] [Related]
10. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Leenen FH; Yuan B Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models. Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170 [TBL] [Abstract][Full Text] [Related]
12. The role of brain angiotensin in thirst and AVP release induced by hemorrhage. Phillips MI; Heininger F; Toffolo S Regul Pept; 1996 Oct; 66(1-2):3-11. PubMed ID: 8899885 [TBL] [Abstract][Full Text] [Related]
13. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Kawano Y; Yoshida K; Matsuoka H; Omae T Am J Hypertens; 1994 Jun; 7(6):536-42. PubMed ID: 7917152 [TBL] [Abstract][Full Text] [Related]
14. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497 [TBL] [Abstract][Full Text] [Related]
15. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II. Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065 [TBL] [Abstract][Full Text] [Related]
16. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action. Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203 [TBL] [Abstract][Full Text] [Related]
17. Sympatho-inhibitory properties of various AT1 receptor antagonists. Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498 [TBL] [Abstract][Full Text] [Related]
19. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060 [TBL] [Abstract][Full Text] [Related]
20. Hypotensive response to losartan in normal rats. Role of Ang II and the area postrema. Collister JP; Hornfeldt BJ; Osborn JW Hypertension; 1996 Mar; 27(3 Pt 2):598-606. PubMed ID: 8613210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]